Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds ACOGF.
No tracked institution reports a position in ACOGF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-11-05 | 1-for-25reverse |
No one on the platform has traded ACOGF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $120M | +319.9% | $0.38 | $0.38–$0.38 | 23.0× | 1 |
| 2027 | $245M | +103.6% | $0.97 | $0.97–$0.97 | 9.1× | 1 |
| 2028 | $331M | +35.0% | $1.36 | $1.36–$1.36 | 6.5× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2024-11-26 | $-0.04 | $-0.31 | -671.1% |
| 2024-08-12 | $-0.01 | $-0.01 | -75.1% |
| $28M |
| — |
| KMSTFKadimastem Ltd | $3.21 | -3.02% | $10M | — |
| LSBCFLakeShore Biopharma Co., Ltd | $0.07 | +0.00% | $3M | — |
Source: Financial Modeling Prep · peers by sector/industry